|Sponsor||Rep. Aderholt, Robert|
|Date||October 7, 2013 (113th Congress, 1st Session)|
|Staff Contact||Kimberly Betz|
On Monday, October 7, 2013, the House will consider H.J.Res. 77, the Food and Drug Safety Act, under a closed rule. H.J.Res. 77 was introduced on October 3, 2013, by Representative Robert Aderholt (R-AL), Chairman, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee on Appropriations.
H.J.Res. 77 provides immediate funding for the Food and Drug Administration at the same rate and under the same conditions as in effect at the end of the just completed fiscal year. Funds are available until another appropriation bill (such as regular bill or CR) is enacted for these operations or December 15, 2013.
Funding for the Food and Drug Agency is included in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill. The FDA’s core functions include: overseeing medical products and tobacco, foods and veterinary medicine, global regulatory operations and policy, and operations. For FY 2014, approximately $2.5 billion in discretionary funding was included for FDA activities by the House Appropriations Committee, $24 million above enacted FY 2013 levels. Total funding including revenue from user fees is $4.3 billion. On October 1, 2013, a lapse in federal funding resulted in a federal government shut down, impacting FDA activities such as routine food inspections. 
CBO estimates that enacting H.J.Res. 77 would result in budget authority of $2.3 billion.